# US 2023/0066836 A1 · Antioxidant Extracts and Compositions

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0066836 A1
- Document ID: US20230066836A1
- Status: Published application
- Kind: A1
- Application number: 17/789,893
- Filed: 2020-12-22
- Published: 2023-03-02
- Earliest claimed: 2019-12-30
- Assignees: NextFerm Technologies Ltd.
- Applicants: NextFerm Technologies Ltd.
- Inventors: Gai Ben-Dor; Yael Lifshitz; Avi Yosef; Tzafra Cohen; Arkadiy Haikin; Masha Fridman; Marina Khutorian; Sivan Mor Danan
- Web page: https://patentgrep.com/patent/US20230066836A1

## CPC

- A61K 36/062: Ascomycota
- A61K 36/07: Basidiomycota, e.g. Cryptococcus
- A23L 33/105: Plant extracts, their artificial duplicates or their derivatives
- A23L 33/175: Amino acids
- A61K 31/122: having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A61K 31/198: Alpha-amino acids, e.g. alanine or edetic acid [EDTA] (betaine A61K31/205; proline A61K31/401; tryptophan A61K31/405; histidine A61K31/4172; peptides not degraded to individual amino acids A61K38/00)
- A61K 33/00: Medicinal preparations containing inorganic active ingredients
- A61K 33/30: Zinc; Compounds thereof
- A61K 33/34: Copper; Compounds thereof
- A61P 39/06: Free radical scavengers or antioxidants
- A61K 2236/00: Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K 2236/35: Extraction with lipophilic solvents, e.g. Hexane or petrol ether
- A61K 2236/53: Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention relates to processes for preparing antioxidant liquid extracts and compositions and uses of such antioxidant liquid extracts and compositions. Also provided are novel antioxidant liquid extracts and compositions comprising astaxanthin. The antioxidant liquid extracts and compositions inter alia exhibit high antioxidant activity.

## Claims

### Claim 1

A process for preparing an antioxidant composition, wherein the process comprises the following steps:
(a) contacting a Phaffia rhodozyma cell biomass with an organic solvent to form a mixture;
(b) performing a solid-liquid separation to remove cell debris from the mixture;
(c) evaporating the solvent from the product obtained from step (b);
(d) heating and cooling the product obtained from step (c) to obtain an antioxidant liquid extract;
(e) separating the solid from the liquid of the antioxidant liquid extract by performing a solid-liquid separation;
(f) mixing the solid obtained from step (e) with water; and
(g) performing a solid-liquid separation to obtain a solid antioxidant composition.

### Claim 2 (depends on 1)

The process for preparing an antioxidant liquid extract according to claim 1, wherein the product obtained from step (c) is heated to a temperature of about 40 to about 85° C.

### Claim 3 (depends on 1)

The process for preparing an antioxidant liquid extract according to claim 1, wherein the cooling is performed at a temperature of lower than about 40° C.

### Claim 4 (depends on 1)

The process for preparing an antioxidant composition according to claim 1, wherein in step (f) the water is mixed with the solid obtained from step (e) at a weight of solid:weight of water ratio of between 1:2 to 1:50.

### Claim 5

An antioxidant liquid extract derived from Phaffia rhodozyma, wherein the liquid extract is composed of two distinct fractions: a solid fraction comprising solid astaxanthin and an oil fraction comprising dissolved astaxanthin.

### Claim 6 (depends on 5)

The antioxidant liquid extract according to claim 5, wherein at least about 10% (w/w) of the astaxanthin comprised in the antioxidant liquid extract is in the form of solid astaxanthin.

### Claim 7

An antioxidant composition derived from Phaffia rhodozyma, wherein the antioxidant composition comprises:
astaxanthin; and
at least one amino acid, or
at least one metal selected from the group consisting of copper, manganese and zinc, or
phospholipids;
wherein the antioxidant composition is a solid.

### Claim 8 (depends on 7)

The antioxidant composition according to claim 7, wherein the at least one amino acid is selected from the group consisting of valine, leucine, isoleucine, proline, glycine and phenylalanine.

### Claim 9 (depends on 7)

The antioxidant composition according to claim 7, wherein the antioxidant composition comprises copper in an amount of at least about 1 ppm; manganese in an amount of at least about 0.5 ppm; and/or zinc in an amount of at least about 10 ppm.

### Claim 10 (depends on 7)

The antioxidant composition according to claim 7, wherein the antioxidant composition is dispersed in an oil, or wherein the antioxidant composition is in the form of a powder.

### Claim 11 (depends on 5)

An oral dosage form comprising the antioxidant liquid extract according to claim 5.

### Claim 12 (depends on 5)

A dietary supplement, a nutritional supplement, a food supplement, a beverage supplement, or a food additive comprising an antioxidant liquid extract according to claim 5.

### Claim 13 (depends on 5)

The antioxidant liquid extract according to claim 5 for use in therapy.

### Claim 14 (depends on 5)

The antioxidant liquid extract according to claim 5 for use in the treatment and/or prevention of a disease selected from a chronic inflammatory disease, a cardiovascular disease, a neurodegenerative disease, a cancer, an autoimmune disease, and a liver disease.

### Claim 15 (depends on 7)

The antioxidant composition according to claim 7, wherein the antioxidant composition is dispersed in an edible oil.

### Claim 16 (depends on 7)

An oral dosage form comprising the antioxidant composition according to claim 7.

### Claim 17 (depends on 5)

A method of preventing muscle damage and/or reducing joint and muscle soreness after exercise comprising administering to a human an antioxidant liquid extract according to claim 5.

### Claim 18 (depends on 11)

A method of preventing muscle damage and/or reducing joint and muscle soreness after exercise comprising administering to a human an oral dosage form according to claim 11.

### Claim 19 (depends on 11)

A dietary supplement, a nutritional supplement, a food supplement, a beverage supplement, or a food additive comprising an oral dosage form according to claim 11.
